Survivorship and Outcomes of Robot Assisted Medial Partial Knee Replacement
This trial is active, not recruiting.
|Condition||unicompartmental knee arthroplasty|
|Treatment||makoplasty® medial uka|
|Sponsor||Northwest Surgical Specialists, Vancouver|
|Collaborator||Stryker MAKO Corp|
|Start date||April 2013|
|End date||May 2021|
|Trial size||139 participants|
|Trial identifier||NCT01845597, 2016-006, MAKO-03|
The purpose of this study is to determine the survivorship rate of robotic assisted medial partial knee replacement at a two, five, and ten years.
10 Year Survivorship of Components
time frame: 10 years after surgery
5 Year Survivorship of Components
time frame: 5 years after surgery
2 year Survivorship of Components
time frame: 2 years after surgery
Male or female participants at least 21 years old.
Inclusion Criteria: - over 21 years of age - underwent primary robotically guided UKA and received a medial MCK onlay implant by the investigating surgeon - at least 24 months post-operative Exclusion Criteria: - Patients will be excluded from participation in the study if they are cognitively unable to answer study questions
|Official title||Survivorship and Outcomes of Robotically Assisted Medial UKA|
|Description||The purpose of this study is to determine the survivorship rate of robotically guided MultiCompartmental Knee system (MCK) medial onlay Unilateral Knee Arthroplasty (UKA) implants at a two, five, and ten year follow up.|
Call for more information